NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)

Award Info:

Awards will be in two multi-year segments of three years and two years. The three-year segment will have an award budget up to $900,000 in direct costs. The two-year segment will have an award budget up to $600,000.

Awardees are required to commit at least three person-months (25%) of their research effort each year to activities supported by the New Innovator Award.


The NIH Director's New Innovator Award is different from traditional NIH grants in several ways. It is designed specifically to support unusually creative investigators with highly innovative research ideas at an early stage of their career when they may lack the preliminary data required for an R01 grant application. The emphasis is on innovation and creativity; preliminary data are not required but may be included. No detailed, annual budget is requested in the application. The review process emphasizes the individual’s creativity, the innovativeness of the research approaches, and the potential of the project, if successful, to have a significant impact on an important biomedical or behavioral research problem.

Applicants must meet the definition of an Early Stage Investigator (ESI) at the time of application.